Table 1. Characteristics of Included Studies.
Source (country) | Data source | Year of data collection | Study design | Median follow-up, y | Participants, No. | Male, % | Age, y | Exposure | Outcomes | Adjustment for covariates | GRACE score | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADHD medication | New or prevalent user | Measure of use | Duration of use, y | Definition | Diseases | ||||||||||
Cooper et al,9 2011 (United States) | Claims | 1986-2005 | Cohort | 2.1 | 1 200 438 | 71 | Mean, 11; range, 2-24 | AMP, MPH, DMPH, ATX, pemoline | Mixeda | Current | NA | ICD-9, ICD-10 | MI, CA, stroke | Demographics, comorbidities, health care utilization | 11 |
Dalsgaard et al,11 2014 (Denmark) | Register | 1990-2008 | Cohort | 9.5 | 8300 | 81 | Mean, 11 | AMP, MPH | Mixeda | Current | 2.5 | ICD-10 | CVD | Demographics, comorbidities, perinatal characteristics | 8 |
Guertin et al,31 2014 (Canada) | Claims | 2001-2010 | NCC | NA | 38 495 | 70 | Mean, 9 | AMP, MPH, ATX | New | Current | NA | ICD-9, ICD-10 | CVD | Demographics | 8 |
Habel et al,10 2011 (United States) | Claims | 1986-2005 | Cohort | 1.3 | 443 198 | 46 | Range, 25-64 | AMP, MPH, ATX, pemoline | Mixeda | Current | 0.33 | ICD-9, ICD-10 | MI, CA, stroke | Demographics, CV risk score | 11 |
Holick et al,32 2009 (United States) | Claims | 2003-2006 | Cohort | 1.5 | 86 205 | 52 | ≥18 | AMP, MPH, ATX | New | Current | NA | ICD-9 | Cerebrovascular disease, TIA | Demographics, comorbidities, comedications | 9 |
Houghton et al,16 2020 (United States) | Claims | 2000-2016 | NCC | NA | 2046 | 68 | Mean, 14; range, 3-18 | AMP, MPH, ATX | Mixeda | Current | NA | ICD-9, ICD-10 | MI, arrhythmia, stroke | Demographics, CV risk, comorbidities, comedications | 9 |
Jeong et al,17 2021 (South Korea) | Claims | 2002-2018 | SCCS | NA | 2104 | 51 | Mean, 58; ≥6 | MPH | New | Current | 2.8 | ICD-10 | MI | Age, comorbidities, comedications | 10 |
Jeong et al,17 2021 (Taiwan) | Claims | 2004-2015 | SCCS | NA | 484 | 64 | Mean, 65; ≥6 | MPH | New | Current | 2.3 | ICD-9 | MI | Age, comorbidities, comedications | 10 |
Jeong et al,17 2021 (Hong Kong) | Clinical data | 2001-2016 | SCCS | NA | 30 | 50 | Mean, 70; ≥48 | MPH | New | Current | 2.3 | ICD-9 | MI | Age, comorbidities, comedications | 10 |
Latronica et al,18 2021 (United States) | EHR | 2018-2020 | Cohort | 2 | 13 233 | 37 | Mean, 70; ≥65 | AMP | Mixeda | Current | NA | ICD-10 | HF, stroke, MI, AF, IHD, arrhythmia | Demographics, BMI, comorbidities | 7 |
Olfson et al,33 2012 (United States) | Claims | 1997-2007 | Cohort | 1.8 | 171 126 | 67 | Range, 6-21 | AMP, MPH | New | Current | NA | ICD-9 | Angina pectoris, arrhythmia, TIA | Demographics, comorbidities, comedications | 9 |
Peyre et al,34 2014 (United States) | National representative survey | 2004-2005 | Cohort | 1 | 807 | 59 | Mean, 40 | Not specified | Mixeda | Ever | NA | Self-report | MI, angina pectoris, stroke | CV risk factors | 5 |
Saiz et al,19 2020 (Spain) | Primary care database | 2002-2014 | NCC | NA | 2882 | 40 | Mean, 14; range, 5-25 | MPH | Mixeda | Current | 0.65 | ICPC, ICD-9 | Valvular heart disease | Age, sex, smoking, comorbidities, comedications | 9 |
Schelleman et al,35 2011 (United States) | Claims | 1999-2006 | Cohort | 1.4 | 241 417 | 72 | Range, 3-17 | AMP, MPH, ATX | New | Current | 0.37 | ICD-9 | Sudden death, ventricular arrhythmia | Data source | 8 |
Schelleman et al,36 2012 (United States) | Claims | 1999-2006 | Cohort | 1.2 | 219 954 | 45 | ≥18 | MPH | New | Current | 0.16 | ICD-9 | MI, stroke | Demographics, comorbidities, comedications | 9 |
Schelleman et al,37 2013 (United States) | Claims | 1999-2006 | Cohort | 1.2 | 192 905 | 46 | ≥18 | AMP | New | Current | 0.24 | ICD-9 | MI, stroke | Demographics, comorbidities, comedications | 9 |
Shin et al,38 2016 (South Korea) | Claims | 2008-2011 | SCCS | NA | 1224 | 78 | Mean, 13; range, ≤17 | MPH | New | Current | 0.5 | ICD-10 | Arrythmias, HF, Hypertension, MI, stroke | Age, comorbidities, comedications | 11 |
Tadrous et al,20 2021 (Canada) | Claims and health care database | 2002-2016 | Cohort | 1 | 31 310 | 49 | Mean, 74; range, ≥66 | AMP, MPH | New | Current | NA | ICD-9, ICD-10 | MI, ventricular arrhythmia, stroke, TIA | Demographics, CVD history, physician visits, comorbidities, comedications | 11 |
Winterstein et al,39 2007 (United States) | Claims | 1994-2004 | Cohort | 2.3 | 55 383 | 70 | Range, 3-20 | AMP, MPH, pemoline | New | Current | NA | ICD-9 | MI, hypertensive diseases, aortic or thoracic aneurysm, arrhythmia, cardiac symptoms | Age, race, congenital anomalies, history of circulatory disease, comorbidities, comedications | 9 |
Winterstein et al,12 2012 (United States) | Claims | 1999-2006 | Cohort | 1.9 | 1 219 847 | 59 | Range, 3-18 | AMP, MPH | Mixeda | Current | NA | ICD-9 | MI, CA, ventricular arrhythmia, stroke | Demographics, CV risk factors, comorbidities, and comedications | 9 |
Zhang et al,40 2015 (United States) | Research sample | 1979-2014 | Cohort | 7.9 | 144 | 62 | Mean, 11 | AMP, MPH, ATX, guanfacine | Mixeda | Current | NA | NA | Syncope, aborted CA | Age, gender, QTc-duration, prior cardiac event, comedications | 6 |
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; AF, atrial fibrillation; AMP, amphetamines; ATX, atomoxetine; BMI, body mass index; CA, cardiac arrest; CV, cardiovascular; CVD, cardiovascular disease; DMPH, dexmethylphenidate; EHR, electronic health record; HF, heart failure; EHR, electronic health records; GRACE, The Good Research for Comparative Effectiveness Checklist; ICD-9, International Classification of Diseases, Ninth Revision; ICD-10, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; ICPC, international classification of primary care; IHD, ischemic heart disease; MI, myocardial infarction; MPH, methylphenidate; NA, not available; NCC, nested case-control; SCCS, self-controlled case series; TIA; transient ischemic attack.
Mixed indicates mixture of incident and prevalent users.